Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Hepatitis B infects over 40 million people in India
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The 200 bedded hospital owned & operated by Alexis
This alliance brings together drug innovation capabilities of Glenmark and Ichnos to develop cutting-edge therapies for the treatment of hematological malignancies and solid tumors
Automated parallel capillary electrophoresis system simplifies protein analysis
Innovent will supply sintilimab for the collaborated clinical trial
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)